DK0832233T3 - Humant kemokin beta-13 - Google Patents

Humant kemokin beta-13

Info

Publication number
DK0832233T3
DK0832233T3 DK95923767T DK95923767T DK0832233T3 DK 0832233 T3 DK0832233 T3 DK 0832233T3 DK 95923767 T DK95923767 T DK 95923767T DK 95923767 T DK95923767 T DK 95923767T DK 0832233 T3 DK0832233 T3 DK 0832233T3
Authority
DK
Denmark
Prior art keywords
disclosed
polypeptides
chemokine polypeptides
detecting
chemokine
Prior art date
Application number
DK95923767T
Other languages
English (en)
Inventor
Haodong Li
George Seibel
Original Assignee
Smithkline Beecham Corp
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Human Genome Sciences Inc filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DK0832233T3 publication Critical patent/DK0832233T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DK95923767T 1995-06-06 1995-06-06 Humant kemokin beta-13 DK0832233T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007294 WO1996039521A1 (en) 1995-06-06 1995-06-06 Human chemokine beta-13

Publications (1)

Publication Number Publication Date
DK0832233T3 true DK0832233T3 (da) 2005-01-24

Family

ID=22249282

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95923767T DK0832233T3 (da) 1995-06-06 1995-06-06 Humant kemokin beta-13

Country Status (10)

Country Link
EP (1) EP0832233B1 (da)
KR (1) KR19990008322A (da)
AT (1) ATE278780T1 (da)
AU (1) AU713267B2 (da)
DE (1) DE69533627T2 (da)
DK (1) DK0832233T3 (da)
ES (1) ES2227553T3 (da)
MX (1) MX9708528A (da)
PT (1) PT832233E (da)
WO (1) WO1996039521A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6498015B1 (en) * 1995-06-07 2002-12-24 Icos Corporation Methods of identifying agents that modulate the binding between MDC and an MDC receptor
US7018627B1 (en) 1995-06-07 2006-03-28 Icos Corporation Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances, and uses thereof
US6737513B1 (en) 1996-06-07 2004-05-18 Icos Corporation Macrophage derived chemokine (MDC) and chemokine analogs and assay to identify modulators of MDC activity, and therapeutic uses for same
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
WO1998011226A2 (en) * 1996-09-10 1998-03-19 Schering Corporation Mammalian chemokines, related reagents
AU7625598A (en) * 1996-12-03 1998-06-29 Amgen, Inc. Novel protein with chemokine activity
CA2277580A1 (en) * 1996-12-05 1998-06-11 Human Genome Sciences, Inc. Human chemokine beta-13
US6852508B1 (en) 1997-02-28 2005-02-08 Genetics Institute, Llc Chemokine with amino-terminal modifications
US6100387A (en) * 1997-02-28 2000-08-08 Genetics Institute, Inc. Chimeric polypeptides containing chemokine domains
US6632425B1 (en) 1997-03-20 2003-10-14 Human Genome Sciences, Inc. Chemokine compositions
US6548631B1 (en) * 1997-09-16 2003-04-15 BIOMéRIEUX, INC. Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection
KR19990042713A (ko) * 1997-11-27 1999-06-15 허일섭 사람에서 분리한 c 6 베타-케모카인 lkn-1의 cdna 및 재조합 lkn-1의 제조방법
US6093542A (en) * 1998-01-09 2000-07-25 Akzo Nobel N.V. Isothermal transcription based amplification assay for the detection and quantitation of macrophage derived chemokine RNA
EP1229795A4 (en) * 1999-11-03 2004-07-28 Human Genome Sciences Inc CHIMIOKINE BETA 13 HUMAN
CA2484121A1 (en) 2002-05-01 2003-11-13 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
MX361929B (es) 2010-11-19 2018-12-19 Eisai R&D Man Co Ltd Star Anticuerpos anti-ligando de quimiocina cc 20 (ccl20) neutralizantes.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92685A0 (en) * 1988-12-16 1990-09-17 Us Commerce Dna encoding lymphokine/cytokine like proteins,cells transformed thereby and production of said proteins and antibodies against them

Also Published As

Publication number Publication date
ATE278780T1 (de) 2004-10-15
EP0832233A1 (en) 1998-04-01
MX9708528A (es) 1998-02-28
DE69533627D1 (en) 2004-11-11
AU2820895A (en) 1996-12-24
WO1996039521A1 (en) 1996-12-12
EP0832233B1 (en) 2004-10-06
ES2227553T3 (es) 2005-04-01
DE69533627T2 (de) 2005-10-13
KR19990008322A (ko) 1999-01-25
AU713267B2 (en) 1999-11-25
EP0832233A4 (en) 1998-07-01
PT832233E (pt) 2004-12-31

Similar Documents

Publication Publication Date Title
MX9708537A (es) Quimiocina beta-8 quimiocina beta-1 y proteina-4 inflamatoria de los macrofagos, humanas.
DK0832233T3 (da) Humant kemokin beta-13
ATE262345T1 (de) Menschliche chemokin-polypeptide
WO1997035010A8 (en) Chemokine alpha 2
DK0799311T3 (da) Human kemokin beta-9
ATE354638T1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
EP0814158A3 (en) Human C3a receptor variant; uses in diagnostics and therapeutics
ES2068791T1 (es) Metodos y acido desoxirribonucleico para la preparacion de proteina de factor de tejido.
DE69841140D1 (de) Interleukin-17 rezeptor-ähnliches protein
DE69433747D1 (de) Calcitoninrezeptor
EP0792370A4 (en) INTERLEUKIN-1 CONVERSION ENZYME-TYPE APOPTOSIS PROTEASE-3 AND 4 -g (b)
WO2003080856A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP0826774A3 (en) Staphylococcal Fab I enoyl-ACP reductase
EP0812913A3 (en) HR-1 receptor, a receptor of the cytokine receptors family
EP0835933A3 (en) A G-protein coupled receptor, HLTEX11
WO2003029423A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
MX9709090A (es) Quimiocina beta-11 humana y quimiocina alfa-1 humana.
EP0845535A3 (en) Leader peptidase (lep) from Streptococcus
EP0837136A3 (en) Novel topoisomerase I
EP0841399A3 (en) Mammalian fin-1 nucleic acid (a caspase) and protein sequences and uses therefor
WO2003085124A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003064589A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003050245A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP0845531A3 (en) Polypeptides and polynucleotides from the Staphylococcus SigB operon
WO2004015079A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use